CG MedTech Co

CG MedTech Co Net Debt per Share

The Net Debt per Share of CG MedTech Co (056090.KQ) as of Oct 15, 2026 is 9.16 KRW. In the previous year, Net Debt per Share was 15.43 KRW — a change of -40.63% (lower).

Net Debt per Share

9.16KRW

YoY

-40.63%

Last updated:

Net Debt per Share of CG MedTech Co is 2025 9.16 KRW. Net Debt per Share of CG MedTech Co was 2024 15.43 KRW. It decreases by -40.63% lower compared to the previous year.

The CG MedTech Co Net Debt per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Debt per Share
Date
Net Debt per Share
Jan 1, 2017
-95.89 KRW
Jan 1, 2018
131.29 KRW
Jan 1, 2019
186.22 KRW
Jan 1, 2020
149.44 KRW
Jan 1, 2021
104.31 KRW
Jan 1, 2022
703.42 KRW
Jan 1, 2024
15.43 KRW
Jan 1, 2025
9.16 KRW
The CG MedTech Co Net Debt per Share history
YEARNet Debt per ShareYoY
9.16KRW-40.63%
15.43KRW-97.81%
703.42KRW+574.37%
104.31KRW-30.20%
149.44KRW-19.75%
186.22KRW+41.84%
131.29KRW-236.92%
-95.89KRW-63.40%
-261.98KRW-360.26%
100.66KRW-33.21%
150.70KRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

CG MedTech Co Stock analysis

What does CG MedTech Co do? CG MedTech Co Ltd, listed on the Korea Exchange with ticker 056090.KQ and ISIN KR7056090004, is a company based in Uijeongbu, South Korea. It operates within the Health Care sector, specifically in the Health Care industry. The company went public on November 12, 2015. Its website is https://inno-sys.net/. CG MedTech Co Ltd focuses on the manufacture of orthopaedic surgical implants and surgical devices. The company's business activities are conducted through two segments: the Medical Device Business segment, which involves the production and sale of spinal fixation devices, micro-invasive medical devices for back pain treatment, fracture treatment devices, and bioabsorbable alloy implants, and the Electric Energy Business segment, which is involved in the production and sale of electricity meters and integrated calorimeters. The company's headquarters are located in Uijeongbu, Gyeonggi-Do. The website provided is associated with the company, though the source description mentions 'Innosys Co. Ltd.' as the company name, which may differ from the official name. The source also indicates that the company's IPO date is November 12, 2015, which aligns with the provided information. The company's operations are centered around medical devices, with a secondary focus on electric energy products. CG MedTech Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about CG MedTech Co stock

Net Debt per Share of CG MedTech Co is 9.16 KRW in 2025.

Net Debt per Share of CG MedTech Co changed from 15.43 KRW to 9.16 KRW, representing a -40.63% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Net Debt per Share CG MedTech Co since 2006 – with annual values, charts, and detailed analysis.

Net debt per share divides net debt by shares outstanding, showing the debt burden attributable to each share after accounting for cash reserves.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Other — CG MedTech Co

All Key Metrics — CG MedTech Co